Results 51 to 60 of about 64,504 (248)

Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart Failure

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Comorbidities like a history of chronic obstructive pulmonary disease (COPD), atrial fibrillation (AF) and heart failure (HF) can cause similar symptoms as aortic stenosis (AS). However, how they influence symptom improvement and long‐term outcomes after transcatheter aortic valve implantation (TAVI) is unclear.
Kees H. van Bergeijk, Constantijn S. Venema, Bob Ophuis, Luca H. Plekkenpol, Mara Tomei, Hayman Al‐Barwary, Jasper Tromp, Yoran M. Hummel, Wouter Ouwerkerk, Ad F. M. van den Heuvel, Hindrik W. van der Werf, Yvonne L. Douglas, Jonas Lanz, Stefan Stortecky, Daijiro Tomii, Thomas Pilgrim, Stephan Windecker, Edoardo Pancaldi, Matteo Pagnesi, Marianna Adamo, Adriaan A. Voors, Joanna J. Wykrzykowska   +21 more
wiley   +1 more source

Imaging techniques in transcatheter aortic valve replacement

Research Reports in Clinical Cardiology, 2013
Robert A Quaife, Jennifer Dorosz, John C Messenger, Ernesto E Salcedo Division of Cardiology, University of Colorado, Aurora, CO, USA Abstract: Calcific aortic stenosis is now understood as a complex valvular degenerative process sharing many risk ...
Quaife RA, Dorosz J, Messenger JC, Salcedo EE   +3 more
doaj  

Early Stent Frame Fracture of SAPIEN 3 Valve in the Pulmonary Position

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT A 15‐year‐old post‐REV patient underwent transcatheter pulmonary valve replacement with a 23 mm SAPIEN 3 for right ventricular outflow tract (RVOT) stenosis and severe regurgitation. At 9 months, recurrent stenosis revealed multiple frame fractures.
Raymond N. Haddad, Clément Batteux, Emre Belli, Sébastien Hascoët   +3 more
wiley   +1 more source

Multicenter experience with a second-generation fully-retrievable and repositionable transcatheter aortic valve

REC: Interventional Cardiology (English Ed.), 2020
Introduction and objectives: The Lotus Valve device (Boston Scientific) is a second-generation fully-retrievable and repositionable transcatheter aortic valve.
Daniele Gemma, Raúl Moreno, Mariano Larman, Rui Campante Teles, Lino Patricio, Eduardo Molina, Vasco Gama Ribeiro, Bruno García Del Blanco, Roque Arana Granado, Santiago Jiménez Valero, Guillermo Galeote, Harold Hernández, Francisco Javier Irazusta Córdoba, Vicenç Serra, José Luis López-Sendón   +14 more
doaj   +1 more source

Comparison of Latest Generation Intra‐ and Supra‐Annular Self‐Expanding Transcatheter Heart Valves for Aortic Valve‐in‐Valve Procedures

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Valve‐in‐valve (ViV) procedures are an established therapy. Self‐expanding (SE) supra‐annular transcatheter heart valves (THV) achieve superior hemodynamics compared to balloon‐expandable (BE) intra‐annular THV, but influence of stent design versus valve position remains unclear.
Antonia Katharina Stötzel, Oliver D. Bhadra, Lara Waldschmidt, Till J. Demal, David Grundmann, Lisa Voigtländer, Stefan Blankenberg, Hermann Reichenspurner, Niklas Schofer, Andreas Schaefer   +9 more
wiley   +1 more source

Aortic Valvuloplasty as Bridging for TAVI in High-Risk Patients with Heyde’s Syndrome: A Case Report

Case Reports in Medicine, 2012
There is a frequent association between aortic valve stenosis and gastrointestinal bleeding, also known as Heyde’s syndrome. In these patients, the aortic valve replacement should be recommended as “gold standard.” In high-surgical-risk patients, the ...
Cosmo Godino, Anna Giulia Pavon, Antonio Mangieri, Alberto Margonato   +3 more
doaj   +1 more source

Low-Gradient, Low Ejection Fraction Severe Aortic Stenosis: Still a Management Conundrum

Cardiovascular Innovations and Applications, 2018
The management of patients with severe symptomatic aortic stenosis and a high transvalvular gradient is straightforward. It requires aortic valve replacement. Management of aortic stenosis patients with low flow, low ejection fraction and low gradient is
Blase A. Carabello
doaj   +1 more source

Transcaval Transcatheter Aortic Valve Replacement: Clinical Outcomes From a TAVI Program Without Prior Transcaval Experience

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Despite the emergence of the transcaval (TCv) access route for transcatheter aortic valve implantation (TAVI) in the treatment of patients with hostile iliofemoral anatomy, the number of patients reported in clinical series of TCv TAVI has been relatively small (< 500 published cases). We assessed procedural and clinical outcomes in
Conor J. Doyle, Brian McGrath, Ronan Margey, Andrew Sharp, Andrew J. Mitchell, Ellen Beirne, Ivan P. Casserly   +6 more
wiley   +1 more source

Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis

Journal of the Saudi Heart Association, 2018
Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned ...
Jarrah Alfadhli, Mohammed Jeraq, Vikas Singh, Claudia Martinez   +3 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation in a Ross Procedure Patient With Severe Autograft Regurgitation: A Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee, Nikhil Joshi, Stephanie Curtis, Mark Turner   +3 more
wiley   +1 more source